Events Partner Content Bridging Clinical Research & Clinical Health Care Collab... To increase participation in clinical research
Events Partner Content Blockchain for Clinical Trials Forum Setting a New Standard for Optimizing Clinical Trials
Events Partner Content Responding to the Opioid Crisis: Litigation, Regulation &... There are numerous pharmaceutical and plaintiff conferences on the opioid crisis, but none that cover the legal and regulatory aspects from BOTH sides of litigation.
Events Partner Content World Congress on Advances In Analytical and Bioanalytical T... Evincing the extant stratagem in Analytical Techniques
Partner Content Partner Content Hear from a Top 100 Global Social Media Influencer of 2017 Dr. Paul Tunnah Presents at Social Media in Pharma 2018
News Gilead strikes again, penning $5bn deal to buy Tubulis Gilead has signed its third acquisition deal since the start of the year, agreeing to buy ADC specialist Tubulis for $3.15bn upfront.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
